5-(furan-2-yl)-4-(p-tolyl)-2,4-dihydro-3H-1,2,4-triazole-3-thione

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 5-(furan-2-yl)-4-(p-tolyl)-2,4-dihydro-3H-1,2,4-triazole-3-thione
• 英文别名: 3-(furan-2-yl)-4-(4-methylphenyl)-1H-1,2,4-triazole-5-thione
• 化学式: C₁₃H₁₁N₃OS
• mdl: MFCD02228931
• 分子量: 257.316
• InChiKey: LNAPTKKFFQVWLE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  18
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.076
• 拓扑面积：
  72.9
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  奥硝唑 、 5-(furan-2-yl)-4-(p-tolyl)-2,4-dihydro-3H-1,2,4-triazole-3-thione 在 potassium carbonate 作用下， 以 丙酮 为溶剂， 反应 21.0h， 以45%的产率得到
  参考文献：
  名称：

  5-Nitroimidazole derivatives as possible antibacterial and antifungal agents

  摘要：

  Some novel 1-[2-[[5-(2-furanyl)-4-substituted 4H-1,2,4-triazol-3-yl]thio]ethyl]-2-methyl-5-nitro-1H-imidazoles (3), 1-[3-[[5-(2-furanyl/2-thienyl)-4-substituted 4H-1,2,4-triazol-3-yl]-thio]-2-hydroxypropyl]-2-methyl-5-nitro-1H-imidazoles (5) and 1-[3-[(N,N-disubstituted thiocarbamoyl)-thio]-2-hydroxypropyl]-2-methyl-5-nitro-1H-imidazoles (7) were synthesized and evaluated for in vitro antibacterial and antifungal activity. Some of 5 were found to be effective against bacteria and fungi (minimum inhibitory concentration (MIC) 7.3-125 mu g/ml), whereas 7 were found to be effective against fungi (MIC 3-25 mu g/ml). (C) 1999 Elsevier Science S.A. AII rights reserved.

  DOI：

  10.1016/s0014-827x(99)00109-3
• 作为产物：
  描述：

  2-呋喃甲酰肼 在 盐酸 、 potassium hydroxide 作用下， 以 乙醇 为溶剂， 生成 5-(furan-2-yl)-4-(p-tolyl)-2,4-dihydro-3H-1,2,4-triazole-3-thione
  参考文献：
  名称：

  一些新型含三唑类环丁烷衍生物的合成、抗氧化和抗肿瘤活性

  摘要：

  摘要 氨基硫脲 (2a-e) 是通过呋喃-2-羧酸酰肼 (1) 与五种不同的异硫氰酸酯 (RNCS) 衍生物的相互作用获得的。通过向反应介质中加入 KOH，得到乙基、烯丙基、苯基和苄基、对甲苯基取代的 1,2,4-三唑（3a-e）。在 2-氯-1-(3-甲基-3-甲基环丁基) 乙酮 (4) 存在下，将 3a-e 溶解在含有 K2CO3 的干燥丙酮中，得到 3,4,5-三取代的 1,2,4-三唑硫烷基含有环丁烷环的化合物 (5a-e)。最终化合物的结构通过元素分析、FT-IR、1H-NMR和13C-NMR确认。还研究了合成化合物的抗氧化和抗肿瘤特性。三种具有对甲苯基的三唑衍生物，与标准品相比，苄基和苯基取代基 (5c-e) 显示出良好的抗氧化和抗肿瘤活性。图形概要

  DOI：

  10.1080/10426507.2019.1597363

文献信息

• Discovery of a New Drug-like Series of OGT Inhibitors by Virtual Screening
  作者：Elena M. Loi、Tihomir Tomašič、Cyril Balsollier、Kevin van Eekelen、Matjaž Weiss、Martina Gobec、Matthew G. Alteen、David J. Vocadlo、Roland J. Pieters、Marko Anderluh

  DOI：10.3390/molecules27061996

  日期：——

  of serious human pathologies, such as diabetes and cancer. However, the limited availability of potent and selective inhibitors hinders the validation of this potential therapeutic target. To explore new chemotypes that target the active site of OGT, we performed virtual screening of a large library of commercially available compounds with drug-like properties. We purchased samples of the most promising

  O -GlcNAcylation 是一种重要的翻译后修饰，由酶O -β- N安装-乙酰-d-氨基葡萄糖转移酶（OGT）。调节这种酶对于更好地了解其在严重的人类疾病（如糖尿病和癌症）发展中的作用非常有价值。然而，有效和选择性抑制剂的有限可用性阻碍了对这种潜在治疗靶点的验证。为了探索针对 OGT 活性位点的新化学型，我们对具有药物样特性的大型商用化合物库进行了虚拟筛选。我们购买了最有希望的虚拟命中的样本，并使用酶分析来识别真正的线索。通过生成一个小型衍生物库来探索最佳鉴定的 OGT 抑制剂的构效关系。我们的最佳作品展示了一种新型尿苷模拟支架，并用 IC 抑制了重组酶50值为 7 µM。当前的成功代表了设计和开发一组新的 OGT 抑制剂的绝佳起点，这可能证明对探索 OGT 的生物学有用。
• Cansiz; Koparir; Demirdag, Molecules, 2004, vol. 9, # 4, p. 204 - 212
  作者：Cansiz、Koparir、Demirdag

  DOI：——

  日期：——
• Synthesis, Characterization, and Evaluation of Antimicrobial Activity of Some 1,2,4-Triazole Derivatives Bearing an Antipyryl Moiety
  作者：Nuray Ulusoy、�znur Ate?、�mer K���kbasmac?、Muammer Kiraz、Y?ld?z Ye?eno?lu

  DOI：10.1007/s00706-002-0546-z

  日期：2003.2.1

  Some novel 4-[[2-[[5-(2-furanyl)-4-alkyl/aryl-4H-1,2,4-triazol-3-yl]thio]-acetyl/propionyl] -amino]-1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazoles were synthesized and evaluated for in vitro antibacterial activity against Staphylococcus aureus ATCC 29213, Pseudomonas aeruginosa ATCC 27853, Escherichia coli ATCC 25922, and Enterococcus faecalis ATCC 29212 and antifungal activity against Candida albicans ATCC 10231, Candida parapsilosis ATCC 22019, Candida krusei ATCC 6258, Candida parapsilosis, Trichophyton mentagrophytes var. erinacei NCPF 375, Microsporum gypseum NCPF 580, and Trichophyton rubrum using the microbroth dilution method. All of the compounds were found to be ineffective against the above bacteria within the applied MIC ranges. On the other hand, they were effective against fungi to different degrees. Three compounds showed high activity against C. parapsilosis and T mentagrophytes var erinacei NCPF 375 (MIC = 8 mug cm(-3)). The in vitro antimycobacterial activity of the new compounds was also investigated against Mycobacterium tuberculosis H37RV (ATCC 27294) in BACTEC 12B medium using a broth microdilution assay, the Microplate Alamar Blue Assay (MABA). Compounds exhibiting fluorescence were tested in the BACTEC 460 radiometric system. The most active compound was found with 66% inhibition at > 6.25 mug cm(-3).
• COMPOUNDS FOR MODULATING RNA BINDING PROTEINS AND USES THEREFOR
  申请人：RYDER Sean

  公开号：US20110065704A1

  公开（公告）日：2011-03-17

  The invention relates to compositions and methods for inhibiting RNA binding proteins (e.g., MEX-3, MEX-5 and POS-1), as well as methods for treating and preventing disorders associated with parasitic infections and inflammatory disorders.
• US8377639B2
  申请人：——

  公开号：US8377639B2

  公开（公告）日：2013-02-19